Drug maker Glenmark Pharmaceuticals today said its consolidated net profit for the financial year ended March 2009 stood at Rs 193.47 crore, while it had a consolidated net profit of Rs 632.11 crore in the same period ended March 2008.

Also Read   Related Stories News Now - Opto Circuits Q4 net up 62% at Rs 55 cr - Power Grid FY09 net up 17% at Rs 1,691 cr - Hinduja Foundries Q4 net loss at Rs 7 cr - Shipping Corp Q4 net drops 19% at Rs 201 cr - Tata Tea FY09 net drops 54% to Rs 700 cr - Crisil downgrades ratings of Glenmark Pharmaceuticals   Also Read   Related Stories News Now - Sensex ends up 130pts - Govt mulls to raise spectrum charges from next year - NTPC seeks govt help to ensure RIL gas supply - Kaya to invest Rs 100 cr on expansion - Govt to do away with lock-in period for FDI in realty More

"The net profit figures are not comparable due to out-licensing revenue received in the last financial year 07-08 amounting to Rs 240.27 crore and one time write offs taken in this financial year 08-09," Glenmark Pharma said in a filing to the Bombay Stock Exchange.

“Due to the global financial crisis which impacted every market in the world, one-off extraordinary items and delay in product approvals by USFDA, the overall business got impacted severely in the financial year.

"Having said that, we began taking corrective measures in the fourth quarter itself and you will see the impact of these initiatives in this financial year," Glenmark Pharmaceuticals, CEO & MD Glenn Saldanha said.

Revenue increased to Rs 2,121.53 crore for the period ended March 2009, from Rs 19,82.06 crore in the same period last year.

Glenmark Generics Inc, USA, posted revenue of Rs 733.77 crore for FY09 against revenue of Rs 564.02 crore, a growth of 30 per cent over the previous year.

The board of directors of the company proposed a dividend of Rs 0.40 for the financial year 2008-2009 subject to the approval of the shareholders.

Other Stories      - Sensex ends up 130pts - Govt mulls to raise spectrum charges from next year - NTPC seeks govt help to ensure RIL gas supply - Kaya to invest Rs 100 cr on expansion - Govt to do away with lock-in period for FDI in realty More

Tags : Glenmark Pharma | net profit | Drug maker | corporate results | financial results   Read Business news in  Advertisements   Get financial advisory and solutions for your projects   Holidays starting at a delightful EMI of Rs 3481   Switch on and say hello to Monday morning !   Your dream home can now be a reality.   Visit Fortis for a preventive health check-up & get a 20% discount.   Follow the ups and downs of your investments. Try our new Portfolio Tracker   Kolkata Dock \ Freight contract for the British Gurkhas Nepal   Find how Midsize Businesses use ERP to gain competitive advantage   Trading in Forex is now as easy as 1-2-3   Discover an economical and cost effective way to market your products and services   Giftwithlove.com: Same day delivery of Flowers and Cakes to India   Download the E-book on the Future of Business Intelligence   Learn Best Practices for improving customer satisfaction   Know your customers better... download the free e-book on CRM